This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.
We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.
Sensyne Health is a clinical artificial intelligence company operating a unique business model. We are a for-profit plc making a positive social impact, sharing the financial returns we make with the health systems via equity and a share of revenues.
Sensyne Health and Chelsea and Westminster NHS Foundation Trust have co-developed SYNE-COV, a patient outcome prediction algorithm that helps clinicians proactively manage COVID-19 patients in hospital.
We deliver remote patient monitoring and real time decision making systems for healthcare organisations and their patients.
We undertake research by analysing large complex de-identified and anonymised data sets to help life sciences companies accelerate the development of new medicines.
MagnifEye is an AI-powered software product that transforms any smartphone into an easy-to-use Lateral Flow Test (LFT) reader.
More about MagnifEye
Our Strategic Research Agreements (SRAs) with healthcare providers allow us access to globally unique, longitudinal de-identified and anonymised patient datasets.
Strategic Research Agreements
© 2021 Sensyne Health plc. All rights reserved.
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives
